RE:RE:RE:RE:RE:RE:1.2 billion fully diluted shares but $50 billion...This is actually a great deal,,,if,,,,,xB3 dont work,,,,it is an absolute embarrassment if it does! I bought the risk in the clinic,,not the risk from poor management!
We are said to have deals with payouts of upwards of $200 Million dollars,,,,,,was that not said!!!,,add up the present deals,,,,,,,shelve xB3 for data to come out,,,,,do a PP to pay off our debt,,,,,,wait it out for 2 more years with full control of our technology!! ,,,,,,and yet our management team is allowing us to go on the block for $4 million dollars?????,,,,,stop this insanity!!,,,,,lots of options left for BTI!!
Salterelli was so sub-dued on the webinar,,,,,he looked stunned ,,,probably shocked at the lack of ability and progress by the senior team.
Old west robbery!!!,,White collar crime!!!!,,,,,and us with a greater market cap by 50% becoming the least in proportion in Biodexa...and smaller than the entity buying us or merging us!! What worst taste in a shareholders mouth could one envision???
The only answer is a no vote. The retail shareholders will appoint new management and a new BoD for Bioasis.
A big fat..... NO,,,,,,,, will be in on proxyvote!!!